We demonstrated that the potent anti-angiogenic effect of miR-192 stems from its ability to globally downregulate angiogenic pathways in cancer cells through regulating two key transcription factors, EGR1 and HOXB9 (Fig. 6). Here, EGR1 is linked to cancer.